Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Monitoring of N-Terminal Brain Natriuretic Peptide after surgery to identify patients at high risk of a major vascular complication
FY 2013-14
Summary
More than 200 million major surgeries are performed on adults each year. Ten million of these patients will die or have a heart attack within the first 30 days after their surgery. The majority of these complications take place within the first three days of surgery when patients are taking high doses of pain medications. As a result more than 65% of these patients will not experience any warning symptoms such as chest pain before experiencing this life-threatening event. As such patients who suffer a heart attack after surgery have a greater chance of dying than those suffering a heart attack outside of surgery. This is because many heart attacks after surgery go unrecognized and untreated.
Predication models exist to help notify physicians of which patients are at highest risk of a vascular complication after surgery. However these tools are only based upon variables before surgery and do not account for the immense cardiovascular insults that surgery inflicts.
Cells in the heart secrete a hormone called N-terminal fragment BNP (NT-proBNP) into the blood when the heart muscle is stretched or stressed. Values of NT-proBNP have the potential to quantify the cardiovascular insults during surgery and may help predict those who will suffer a vascular complication. High levels of NT-proBNP have already been able to predict death and cardiovascular complications in patients in the emergency room setting. Recently small studies have suggested that an increase in the NT-proBNP levels early after surgery is able to identify patients who will have a life threatening heart complication such as a heart attack up to 180 days after surgery.
Using NT-proBNP after surgery may allow doctors to identify patients who until now have been experiencing an unrecognized and life-threatening event. For the first time early and patient specific therapies could be given based on NT-proBNP levels to protect and prevent a complication. The implications of NT-proBNP and early intervention would be a substantial reduction in heart attacks after surgery which will undoubtedly reduce healthcare expenditures and prevent disability and death.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
312042
Name
Khan James S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Monitoring of N-Terminal Brain Natriuretic Peptide after surgery to identify patients at high risk of a major vascular complication
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anesthesia; Cardiology; Cardiovascular Medicine; Mortality; Myocardial Ischemia; Perioperative Medicine; Preventative Medicine; Public Health; Surgery
Abstract
More than 200 million major surgeries are performed on adults each year. Ten million of these patients will die or have a heart attack within the first 30 days after their surgery. The majority of these complications take place within the first three days of surgery when patients are taking high doses of pain medications. As a result more than 65% of these patients will not experience any warning symptoms such as chest pain before experiencing this life-threatening event. As such patients who suffer a heart attack after surgery have a greater chance of dying than those suffering a heart attack outside of surgery. This is because many heart attacks after surgery go unrecognized and untreated.
Predication models exist to help notify physicians of which patients are at highest risk of a vascular complication after surgery. However these tools are only based upon variables before surgery and do not account for the immense cardiovascular insults that surgery inflicts.
Cells in the heart secrete a hormone called N-terminal fragment BNP (NT-proBNP) into the blood when the heart muscle is stretched or stressed. Values of NT-proBNP have the potential to quantify the cardiovascular insults during surgery and may help predict those who will suffer a vascular complication. High levels of NT-proBNP have already been able to predict death and cardiovascular complications in patients in the emergency room setting. Recently small studies have suggested that an increase in the NT-proBNP levels early after surgery is able to identify patients who will have a life threatening heart complication such as a heart attack up to 180 days after surgery.
Using NT-proBNP after surgery may allow doctors to identify patients who until now have been experiencing an unrecognized and life-threatening event. For the first time early and patient specific therapies could be given based on NT-proBNP levels to protect and prevent a complication. The implications of NT-proBNP and early intervention would be a substantial reduction in heart attacks after surgery which will undoubtedly reduce healthcare expenditures and prevent disability and death.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Khan, James S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~